ClinOne, a clinical trial management software provider based in Colorado, US, announced its corporate entry in Europe by opening an office in the UK, as it looks to improve its coverage to customers and answer market needs in the region.
The announcement follows the company’s opening of an office in Philadelphia, US, in 2019, and is supported, according to the company, by the ‘availability of dedicated staff’.
Rob Bohacs, the company’s CEO, stated that ClinOne has “a large number of global pharmaceutical clients across Europe,” specifically in the UK, France, Germany, Switzerland, Sweden, Poland, and Israel.
A spokesperson for the company told us that ClinOne intends to focus its activity on other European countries as well, such as Spain and Greece.
According to the company, its customer base spans approximately 1,900 institutions across 55 countries.
Regarding its choice to open the office in the UK, the company stated that the country represents an ‘exceptional’ location in Europe, housing more than 400 pharmaceutical and biotech companies.
“The UK is also home to tremendous clinical research talent which will allow ClinOne to continue expanding their team with world-class talent,” the company added.
